Global EditionASIA 中文双语Français
Lifestyle
Home / Lifestyle / Health

Two sessions: Let TCM benefit whole world

By Yang Xiaoyu | chinadaily.com.cn | Updated: 2020-05-29 11:10
Share
Share - WeChat
An employee operates a machine at a modern TCM manufacturing shop of TCM product developer Tasly Pharmaceutical in Tianjian on May 10, 2020. [Photo provided to chinadaily.com.cn]

Motions and proposals on promoting traditional Chinese medicine (TCM) overseas to benefit the whole world were championed at this year's two sessions.

"TCM has played a big role in China's fight against the coronavirus, but as the epidemic wanes in China, it's still rampant in many other countries. Hence, we need to unleash TCM's potential to help more by pushing it into the world's mainstream market as soon as possible," CPPCC member Yu Shengchen, president of Beijing-based Youcare Pharmaceutical Group, said.

By the end of March, among the 91.5 percent of confirmed COVID-19 cases on the mainland who received TCM treatment combined with Western medicine, over 90 percent of them saw the effectiveness, data from National Health Commission shows. This demonstrated the overall effectiveness of TCM in coping with a public health emergency, Yu said, adding that unleashing TCM's potential requires cultivating international talent.

"Not only local professionals with language capabilities but also international students studying TCM in China should be nurtured, as they are important forces for TCM's globalization and promoting the culture behind it," Yu said.

1 2 3 4 Next   >>|
Most Popular
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US